Ligand Pharmaceuticals Management to Present at Two Investor Conferences in March

On March 2, 2020 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reported that senior management will present at two upcoming investor conferences (Press release, Ligand, MAR 2, 2020, View Source [SID1234555039]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Management will deliver a company presentation at the Barclays Global Healthcare Conference on Tuesday, March 10th at 2:35 p.m. ET taking place in Miami Beach, FL.
Management will deliver a company presentation at the 32nd Annual Roth Conference on Monday, March 16th at 1:30 p.m. ET taking place in Dana Point, CA.
The audio portion of the presentations will be available on the Investors page of the Ligand Pharmaceuticals website at View Source